BMJ evidence-based medicine Journal Citation Rate 2026

ISSN 2515-446X eISSN 2515-4478 BMJ GB

Q1 Quartile Top Tier

About BMJ evidence-based medicine
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

BMJ evidence-based medicine (BEM) is a peer-reviewed academic journal covering Blood Pressure and Hypertension Studies and Clinical practice guidelines implementation, published by BMJ in GB, catalogued under ISSN 2515-446X (e-ISSN 2515-4478). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 5.37 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model. OpenAlex records 4,632 works and 31,456 citations, with an h-index of 69.

Authors typically receive a first decision in around 105 days.

BMJ evidence-based medicine Citation Rate 2026 — In Context

BMJ evidence-based medicine has a 2025 2-Year Citation Rate (OpenAlex) of 5.37, placing it in the Q1 quartile within the Blood Pressure and Hypertension Studies research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

BMJ evidence-based medicine operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view. Average submission-to-decision turnaround is approximately 105 days.

Researchers looking to publish in BMJ evidence-based medicine should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare BMJ evidence-based medicine against similar journals in the field, use our journal comparison tool.

Submission Tips for BMJ evidence-based medicine
  • Be prepared for a longer review cycle — decisions typically take around 105 days.
  • This journal covers Blood Pressure and Hypertension Studies, Clinical practice guidelines implementation, Health Sciences Research and Education. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How BMJ evidence-based medicine Compares
Citation Rate vs Field Avg
+123%
Field avg: 2.41

Compared against 32 journals in the same research areas.

ISSN (Print) 2515-446X
ISSN (Online) 2515-4478
Publisher BMJ
Country United Kingdom
APC / Cost Inquire with Publisher
Review Speed ~105 days to first decision
In-depth profile & metrics

BMJ evidence-based medicine is published by BMJ and based in United Kingdom.

In our subject taxonomy, BMJ evidence-based medicine is classified under Blood Pressure and Hypertension Studies, Clinical practice guidelines implementation, Health Sciences Research and Education and Health Systems, Economic Evaluations, Quality of Life.

For prospective authors, BMJ evidence-based medicine returns a first decision in about 105 days (longer for its field).

Its most recent citation rate stands at 5.370.

Research Areas
Links
Frequently Asked Questions about BMJ evidence-based medicine

BMJ evidence-based medicine does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 5.370 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, BMJ evidence-based medicine is not an open access journal.

The average time from submission to first decision at BMJ evidence-based medicine is approximately 105 days.

BMJ evidence-based medicine is published by BMJ.

BMJ evidence-based medicine is not currently listed in the major indexes we track (Scopus, DOAJ, Web of Science). This is not evidence of predatory practice — many legitimate new or regional journals are not yet indexed — but you should verify its peer-review process, editorial board, and indexing directly with the publisher before submitting.

The ISSN of BMJ evidence-based medicine is 2515-446X. Its electronic ISSN (eISSN) is 2515-4478.

BMJ evidence-based medicine sits in the Q1 quartile based on its latest impact factor of 5.37, ranked across all journals in our database.
Live Indexing Status
Updated May 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
5.370
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 5.370 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Journal Metrics
105
Days to Decision
Compare Journals

Compare BMJ evidence-based medicine against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: May 21, 2026

Updated by: system

Get weekly updates for Blood Pressure and Hypertension Studies journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google